Actively Recruiting
Patient Engagement in Using the Technology for Self-Tracking Medication Safety Events in Lung, Colorectal, Breast, and Prostate Cancer
Led by University of Michigan Rogel Cancer Center ยท Updated on 2026-01-21
80
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
U
University of Michigan Rogel Cancer Center
Lead Sponsor
A
Agency for Healthcare Research and Quality (AHRQ)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating a self-monitoring platform designed to help patients with lung, colorectal, breast, and prostate cancer track medication safety events and concerns. This study focuses on patients receiving oral anticancer agents who face challenges managing complex treatment plans, potential toxicities, and interactions at home. The goal is to support patients in becoming vigilant partners in managing their medication and reporting issues to clinicians during care transitions. Participants use an online platform to record their experiences and concerns related to their cancer medications over six months. They may also receive educational materials and follow-up contacts from nurse practitioners as needed. After the initial six-month period, patients are encouraged to continue using the self-monitoring platform for an additional six months if they wish. During the study, researchers will assess usability, usefulness, ease of use, patient engagement, medication self-management ability, symptom distress, quality of life, and healthcare utilization including emergency room visits and hospitalizations. Data will be gathered through surveys, interviews, electronic health record reviews, and system usage tracking up to twelve months. The study aims to understand how this platform supports medication safety and patient activation in cancer care.
CONDITIONS
Brief Title
A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participants are adult patients (aged 18 years or older)
- Diagnosed with lung, colorectal, breast, or prostate cancer
- Are currently receiving active cancer treatments
- Are self-managing one or more prescribed cancer medications
- Have access to technology devices (smartphone, tablet, computer) or have family support to access these devices
- Speak and read English or have a support person who can assist
You will not qualify if you...
- Cannot access or do not use technology
- Do not have access to the internet
- Do not speak or read English
- Not permitted to participate by their health care providers
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote) for eligibility assessment
Duration - 6 months
Participants use a self-monitoring platform at home to track medication safety events and concerns. They may receive educational materials and follow-up contact from a nurse practitioner as needed over this time.
Ongoing use at home with follow-up contacts as needed
Duration - Up to 6 additional months
Participants are encouraged to continue using the self-monitoring platform as desired to support ongoing medication safety tracking and management.
No scheduled visits; participant-driven use of the platform
Trial Site Locations
Total: 1 location
1
University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, United States, 48109
Actively Recruiting
Research Team
Y
Yun Jiang
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here